IA
NKTR icon

IFP Advisors’s Nektar Therapeutics NKTR Stock Holding History

IFP Advisors’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-59
Closed -$3.36K – 4987
2025
Q3 		$3.36K Sell
59
-4,751
-99% -$157K ﹤0.01% 3462
2025
Q2 		$10.6K Buy
+4,810
New +$54K ﹤0.01% 2880
2023
Q1 		– Sell
-16
Closed -$2K – 4067
2022
Q4 		$2K Sell
16
-1
-6% -$48 ﹤0.01% 4190
2022
Q3 		$3K Hold
17
– – ﹤0.01% 4241
2022
Q2 		$3K Hold
17
– – ﹤0.01% 4005
2022
Q1 		$3K Buy
+17
New +$2.52K ﹤0.01% 4005
2021
Q4 		– Sell
-2
Closed -$1K – 3445
2021
Q3 		$1K Hold
2
– – ﹤0.01% 3074
2021
Q2 		$1K Hold
2
– – ﹤0.01% 2921
2021
Q1 		$1K Hold
2
– – ﹤0.01% 2852
2020
Q4 		$1K Hold
2
– – ﹤0.01% 2790
2020
Q3 		$1K Hold
2
– – ﹤0.01% 2675
2020
Q2 		$1K Sell
2
-2
-50% -$624 ﹤0.01% 2573
2020
Q1 		$2K Buy
+4
New +$1.24K ﹤0.01% 2382
2019
Q1 		$21K Sell
41
-32
-44% -$19K ﹤0.01% 1331
2018
Q4 		$37K Sell
73
-112
-61% -$67.6K ﹤0.01% 1783
2018
Q3 		$169K Buy
185
+75
+68% +$64K 0.01% 1172
2018
Q2 		$81K Sell
110
-3
-3% -$3.46K ﹤0.01% 1614
2018
Q1 		$101K Hold
113
– – ﹤0.01% 1383
2017
Q4 		$101K Buy
113
+1
+0.9% +$591 ﹤0.01% 1395
2017
Q3 		$40K Hold
112
– – ﹤0.01% 2136
2017
Q2 		$33K Sell
112
-60
-35% -$17.3K ﹤0.01% 2253
2017
Q1 		$61K Buy
172
+61
+55% +$13.7K ﹤0.01% 1803
2016
Q4 		$20K Buy
111
+1
+0.9% +$203 ﹤0.01% 2465
2016
Q3 		$28K Buy
110
+10
+10% +$2.58K ﹤0.01% 2193
2016
Q2 		$21K Buy
100
+59
+144% +$13.2K ﹤0.01% 2314
2016
Q1 		$21K Sell
41
-65
-61% -$12.5K ﹤0.01% 1330
2015
Q4 		$27K Buy
+106
New +$21.8K ﹤0.01% 1989

Other funds holding NKTR

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

IFP Advisors's NKTR Position: Q4 2025 in Review

IFP Advisors sold out of Nektar Therapeutics (NKTR) in Q4 2025, closing a stake of 59 shares — an estimated $3.36K sold.

IFP Advisors first reported a position in NKTR in Q4 2015 and held it in 27 quarters. The position peaked at $169K in Q3 2018. 180 funds tracked by Wall St. Rank hold NKTR as of Q4 2025.

  • IFP Advisors reported no remaining Nektar Therapeutics position as of Q4 2025 after selling out during the quarter.
  • IFP Advisors sold 59 Nektar Therapeutics shares in Q4 2025, an estimated $3.36K.
  • IFP Advisors first reported a position in Nektar Therapeutics in Q4 2015 and held it in 27 quarters.
  • IFP Advisors's Nektar Therapeutics position peaked at $169K in Q3 2018.
  • 180 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2025.

Based on IFP Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.